Micro-Rna, Autoantibody And Protein Markers For Diagnosis Of Neuronal Injury - EP2478360

The patent EP2478360 was granted to Banyan Biomarkers on Jun 27, 2018. The application was originally filed on Sep 14, 2010 under application number EP10816275A. The patent is currently recorded with a legal status of "Revoked".

EP2478360

BANYAN BIOMARKERS
Application Number
EP10816275A
Filing Date
Sep 14, 2010
Status
Revoked
Mar 13, 2020
Grant Date
Jun 27, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ABLETT GAUNT WILLIAMSMar 27, 2019LEWIS SILKINADMISSIBLE

Patent Citations (22) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2005260697
DESCRIPTIONUS5270163
DESCRIPTIONUS5475096
DESCRIPTIONUS5567588
DESCRIPTIONUS5595877
DESCRIPTIONUS5637459
DESCRIPTIONUS5660985
DESCRIPTIONUS5670637
DESCRIPTIONUS5683867
DESCRIPTIONUS5696249
DESCRIPTIONUS5707796
DESCRIPTIONUS6010854
DESCRIPTIONUS6011020
DESCRIPTIONUS7456027
INTERNATIONAL-SEARCH-REPORTUS2005260697
OPPOSITIONWO2005029088
OPPOSITIONWO2005106038
OPPOSITIONWO2009100131
SEARCHWO02093174
SEARCHWO2010019553
SEARCHWO2010148391
SEARCHWO2011123844

Non-Patent Literature (NPL) Citations (135) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ADAMS, J.H.; GRAHAM, D.I.; JENNETT, B., "The neuropathology of the vegetative state after an acute brain insult", BRAIN, (2000), vol. 123, pages 1327 - 1338-
DESCRIPTION- AVILA, J.; PEREZ, M.; LUCAS, J.J.; GOMEZ-RAMOS, A.; MARIA, I.S.; MORENO, F.; SMITH, M.; PERRY, G.; HERNANDEZ, F., "Assembly in vitro of tau protein and its implications in Alzheimer's disease", CURR ALZHEIMER RES., (2004), vol. 1, pages 97 - 101-
DESCRIPTION- BARTUS, R.T., "The calpain hypothesis of neurodegeneration: evidence for a common cytotoxic pathway", THE NEUROSCIENTIST, (1997), vol. 3, pages 314 - 327-
DESCRIPTION- BARTUS, R.T., "The calpain hypothesis of neurodegeneration: evidence for a common cytotoxic pathway", THE NEUROSCIENTIST., (1997), vol. 3, pages 314 - 327-
DESCRIPTION- BEER, R.; FRANZ, G.; SRINIVASAN, A.; HAYES, R.L.; PIKE, B.R.; NEWCOMB, J.K.; ZHAO, X.; SCHMUTZHARD, E.; POEWE, W.; KAMPFL, A., "Temporal profile and cell subtype distribution of activated caspase-3 following experimental traumatic brain injury", NEUROCHEM., (2000), vol. 75, pages 1264 - 1273-
DESCRIPTION- BELAY ET AL., ARCH. NEUROL., (2001), vol. 58, pages 1673 - 1678-
DESCRIPTION- BITSCH, A.; HORN, C.; KEMMLING, Y.; SEIPELT, M.; HELLENBRND, U.; STIEFEL, M.; CIESIELCZYK, B.; CEPEK, L.; BAHN, E.; RATZKA, P., "Serum tau protein level as a marker of axonal damage in acute ischemic stroke", EUR. NEUROL., (2002), vol. 47, pages 45 - 51-
DESCRIPTION- BRAMLETT, H.M.; DIETRICH, W.D., "Quantitative structural changes in white and gray matter 1 year following traumatic brain injury in rats", ACTA NEUROPATHOL. (BERL, (2002), vol. 103, pages 607 - 614-
DESCRIPTION- BUKI, A.; OKONKWO, D.O.; WANG K.K.W.; POVLISHOCK, J.T., "Cytochrome c release and caspase activation in traumatic axonal injury", J. NEUROSCI., (2000), vol. 20, pages 2825 - 2834-
DESCRIPTION- BUKI, A.; SIMAN, R.; TROJANOWSKI, J.Q.; POVLISHOCK, J.T., "The role of calpain-mediated spectrin proteolysis in traumatically induced axonal injury", J. NEUROPATHOL. EXP. NEUROL., (1999), vol. 58, pages 365 - 375-
DESCRIPTION- CANU, N.; DUS, L.; BARBATO, C.; CIOTTI, M.T.; BRANCOLINI, C.; RINALDI A.M.; NOVAK, M.; CATTANEO, A.; BRADBURY A.; CALISSANO, P., "Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis", J. NEUROSCI., (1998), vol. 8, pages 7061 - 7074-
DESCRIPTION- CHRISTMAN, C.W.; GRADY, M.S.; WALKER, S.A.; HOLLOWAY, K.L.; POVLISHOCK, J.T., "Ultrastructural studies of diffuse axonal injury in humans", J. NEUROTRAUMA, (1994), vol. 11, pages 173 - 186-
DESCRIPTION- CHUNG, C.W.; SONG, Y.H.; KIM, I.K.; YOON, W.J.; RYE, B.R.; JO, D.G.; WOO, H.N.; KWON, Y.K.; KIM, H.H.; GWAG, B.J., "Proapoptotic effects of tau cleavage product generated by caspase-3", NEUROBIOL. DIS., (2001), vol. 8, pages 162 - 172-
DESCRIPTION- "Circulating Nucleic acids in plasma and Serum (CNAPS) III and serum proteomics", Ann NY Acad Sci, page 1022-
DESCRIPTION- CLARK, R.S.; KOCHANEK, P.M.; WATKINS, S.C.; CHEN, M.; DIXON, C.E.; SEIDBERG, N.A.; MELICK, J.; LOEFFERT, J.E.; NATHANIEL, P.D.; JI, "Caspase-3 mediated neuronal death after traumatic brain injury in rats", J. NEUROCHEM., (2000), vol. 74, pages 740 - 753-
DESCRIPTION- CLIN. CHEM., (2004), vol. 50, pages 206 - 208-
DESCRIPTION- Current Protocols in Protein Science, JOHN WILEY AND SONS-
DESCRIPTION- DAMBINOVA SA; KHOUNTEEV GA; IZYKENOVA GA; ZAVOLOKOV IG; ILYUKHINA AY; SKOROMETS AA, "Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke", CLIN CHEM, (2003), vol. 49, pages 1752 - 1762-
DESCRIPTION- DEUTSCHER, "Guide to Protein Purification", METHODS IN ENZYMOLOGY, (1990), vol. 182-
DESCRIPTION- DHARAP, A; VEMUGANTI, R, J NEUROCHEM., (2010), vol. 113, pages 1685 - 1691-
DESCRIPTION- DIXON, CE ET AL., J NEUROTRAUMA, (1999), vol. 16, no. 2, pages 109 - 22-
DESCRIPTION- DRUBIN, D.G.; KIRSCHNER, M.W., "Tau protein function in living cells", J. CELL BIOL., (1986), vol. 103, pages 2739 - 2746-
DESCRIPTION- EL-HEFNAWAY, T ET AL., CLINICAL CHEM., (2004), vol. 50, no. 3, pages 564 - 573-
DESCRIPTION- FRANZ, G.; BEER, R.; KAMPFL, A.; ENGELHARDT, K.; SCHMUTZHARD, E.; ULMER, H.; DEISENHAMMER, F., "Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury", NEUROLOGY, (1995), vol. 60, pages 1457 - 1461-
DESCRIPTION- GALE, S.D.; JOHNSON, S.C.; BIGLER, E.D.; BLATTER, D.D., "Nonspecific white matter degeneration following traumatic brain injury", J. INT. NEUROPSYCHOL. SOC., (1995), vol. 1, pages 17 - 28-
DESCRIPTION- GARCIA, M.L.; CLEVELAND, D.W., "Going new places using an old MAP: tau, microtubules and human neurodegenerative diseases", CURR. OPIN. CELL BIOL., (2001), vol. 13, pages 41 - 48-
DESCRIPTION- GARCIA-SIERRA F; MONDRAGON-RODRIGUEZ S; BASURTO-ISLAS G, "Truncation of tau protein and its pathological significance in Alzheimer's disease", J ALZHEIMERS DIS., (2008), vol. 14, pages 401 - 9, XP008133272-
DESCRIPTION- HACKENG, TM ET AL., PROC NATL ACAD SCI U S A, (1997), vol. 94, no. 15, pages 7845 - 50-
DESCRIPTION- HASSELMANN, D.O. ET AL., "Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum", CLIN. CHEM., (2001), vol. 47, pages 1488 - 1489, XP002987763-
DESCRIPTION- HIGUCHI, M.; LEE, V.M.; TROJANOWSKI, J.Q., "Tau and axonopathy in neurodegenerative disorders", NEUROMOLECULAR MED., (2002), vol. 2, pages 131 - 150-
DESCRIPTION- JEYASEELAN, K ET AL., STROKE, (2008), vol. 39, pages 959 - 966-
DESCRIPTION- KAMPFL, A.; POSMANTUR, R.M.; ZHAO, X.; SCHMUTZHARD, E.; CLIFTON, G.L.; HAYES R.L., "Mechanisms of calpain proteolysis following traumatic brain injury: implications for pathology and therapy: a review and update", J. NEUROTRAUMA, (1997), vol. 14, pages 121 - 134-
DESCRIPTION- KIRALY M; KIRALY SJ., "Traumatic brain injury and delayed sequelae: a review--traumatic brain injury and mild traumatic brain injury (concussion) are precursors to later-onset brain disorders, including early-onset dementia", SCIENTIFICWORLDJOURNAL, (20071112), vol. 7, pages 1768 - 76-
DESCRIPTION- KNOBLACH, S.M.; NIKOLAEVA, M.; HUANG, X.; FAN, L.; KRAJEWSKI, S.; REED, J.C.; FADEN, A.I., "Multiple caspases are activated after traumatic brain injury: evidence for involvement in functional outcome", J. NEUROTRAUMA, (2002), vol. 19, pages 1155 - 1170-
DESCRIPTION- KOBEISSY FH ET AL., MOL CELL PROTEOMICS, (2006), vol. 5, pages 1887 - 1898-
DESCRIPTION- KOSIK, K.S.; FINCH, E.A., "MAP2 and tau segregate into dendritic and axonal domains after the elaboration of morphologically distinct neurites: an immunocytochemical study of cultured rat cerebrum", J. NEUROSCI., (1987), vol. 7, pages 3142 - 3153-
DESCRIPTION- KOVESDI E; LUCKL J; BUKOVICS P; FARKAS 0; PAL J; CZEITER E; SZELLAR D; DOCZI T; KOMOLY S; BÜKI A., "Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics", ACTA NEUROCHIR (WIEN, (2010), vol. 152, no. 1, pages 1 - 17, XP019783086-
DESCRIPTION- KRISHNAMURTHY, S.; SNEIGE, N., "Molecular and biologic markers of premalignant lesions of human breast", ADV. ANAT. PATHOL., (2002), vol. 9, pages 185 - 197-
DESCRIPTION- LEE ET AL., PHARMACOLOGICAL RESEARCH, (2006), vol. 23, pages 312 - 328-
DESCRIPTION- LEI, P. ET AL., BRAIN RES.-
DESCRIPTION- LEI, P ET AL., BRAIN RESEARCH, (2009), vol. 1284, pages 191 - 201-
DESCRIPTION- LEON, SA ET AL., PATIENTS CANCER RESEARCH, (1977), vol. 3 7, page 646-
DESCRIPTION- MCCRACKEN, E.; HUNTER, A.J.; PATEL, S.; GRAHAM, D.I.; DEWAR, D., "Calpain activation and cytoskeletal protein breakdown in the corpus callosum of head- injured patients", J NEUROTRAUMA, (1999), vol. 16, pages 749 - 761-
DESCRIPTION- MCINTOSH, T.K.; SMITH, D.H.; MEANEY, D.F.; KOTAPKA, M.J.; GENNARELLI, T.A.; GRAHAM, D.I., "Neuropathological sequelae of traumatic brain injury: relationship to neurochemical and biomechanical mechanisms", LAB. INVEST., (1996), vol. 74, pages 315 - 341-
DESCRIPTION- MCKEE AC; CANTU RC; NOWINSKI CJ; HEDLEY-WHYTE ET; GAVETT BE; BUDSON AE; SANTINI VE; LEE HS; KUBILUS CA; STERN RA., "Chronic traumatic encephalopathy in athletes: progressive tauopathy after repetitive head injury", J NEUROPATHOL EXP NEUROL., (2009), vol. 68, no. 7, pages 709 - 35-
DESCRIPTION- MEDANA, I.M.; ESIRI, M.M., "Axonal damage: a key predictor of outcome in human CNS diseases", BRAIN, (2003), vol. 126, pages 515 - 530-
DESCRIPTION- MENKE, TM; WARNECKE, JM, ANN NY ACAD. SCI, (2004), vol. 1022, pages 185 - 189-
DESCRIPTION- Methods in Neurosciences, ACADEMIC PRESS-
DESCRIPTION- MULLER, H.M. ET AL., EXPERT REV MOL. DIAGN., (2003), vol. 3, page 443-
DESCRIPTION- NATH ET AL., J NEUROCHEM., (1998), vol. 71, pages 186 - 195-
DESCRIPTION- NATH, R.; PROBERT, A., JR.; MCGINNIS, K.M.; WANG, K.K.W., "Evidence for Activation of Caspase-3-like Protease in Excitotoxins- and Hypoxia/hypoglycemia-Injured Neurons", J. NEUROCHEM., (1998), vol. 71, pages 186 - 195-
DESCRIPTION- Neuromethods, HUMANA PRESS-
DESCRIPTION- NEWCOMB JK; KAMPFL A; POSMANTUR RM; ZHAO X; PIKE BR; LIU SJ; CLIFTON GL; HAYES RL., "Immunohistochemical study of calpain-mediated breakdown products to alpha-spectrin following controlled cortical impact injury in the rat", J. NEUROTRAUMA., (1997), vol. 14, pages 369 - 383-
DESCRIPTION- PATTYN, F ET AL., NUCLEIC ACIDS RESEARCH, (2003), vol. 31, no. 1, pages 122 - 123-
DESCRIPTION- PETTUS, E.H.; CHRISTMAN, C.W.; GIEBEL, M.L.; POVLISHOCK, J.T., "Traumatically induced altered membrane permeability: its relationship to traumatically induced reactive axonal change", J. NEUROTRAUMA, (1994), vol. 11, pages 507 - 522-
DESCRIPTION- PIKE, B.R.; ZHAO, X.; NEWCOMB, J.K., WANG, K.K.W.; POSMANTUR, R.M.; HAYES, R.L., "Temporal relationships between de novo protein synthesis, calpain and caspase 3-like protease activation, and DNA fragmentation during apoptosis in septo- hippocampal cultures", J. NEUROSCI. RES., (1998), vol. 52, pages 505 - 520-
DESCRIPTION- POGUE, AI ET AL., NEUROSCI. LETT., (2010), vol. 476, pages 18 - 22-
DESCRIPTION- POSMANTUR, R.; KAMPFL, A.; SIMAN, R.; LIU, J.; ZHAO, X.; CLIFTON, G.L.; HAYES R.L., "A calpain inhibitor attenuates cortical cytoskeletal protein loss after experimental traumatic brain injury in the rat", NEUROSCIENCE, (1997), vol. 77, pages 875 - 88-
DESCRIPTION- RAINER, TH ET AL., CLIN CHEM, (2003), vol. 49, pages 562 - 560-
DESCRIPTION- RAINER, TH ET AL., "Effects of filtration on glyceraldehydes -3-phosphate dehydrogenase mRNA in the plasma of trauma patients and healthy individuals", CLIN. CHEM., (2004), vol. 50, pages 206 - 208-
DESCRIPTION- RAINER, TH ET AL., "Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke", CLIN CHEM., (2003), vol. 49, pages 562 - 560-
DESCRIPTION- RAO MV; MOHAN PS; PETERHOFF CM; YANG DS; SCHMIDT SD; STAVRIDES PH; CAMPBELL J; CHEN Y; JIANG Y; PASKEVICH PA, "Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST overexpression", J NEUROSCI., (2008), vol. 28, no. 47, pages 12241 - 54-
DESCRIPTION- "Real-time Quantitative PCR Measurement of Circulatory Rhodopsin mRNA in Healthy Subjects and Patients with Diab etic Retinopathy. In Circulating Nucleic acids in plasma and Serum (CNAPS) III and serum", HMAOUIM K.; BUTT, A.; POWRIE, J.; SWAMINATHAN, R., Ann NY Acad Sci, (2004), vol. 1022, pages 152 - 156-
DESCRIPTION- REDELL, JB ET AL., J NEUROSCI. RES., (2009), vol. 87, pages 1435 - 48-
DESCRIPTION- REDELL, J ET AL., J NEUROSCI. RES., (2009), vol. 87, pages 1435 - 1448-
DESCRIPTION- ROHN, T.T.; RISSMAN, R.A.; HEAD, E.; COTMAN, C.W., "Caspase Activation in the Alzheimer's Disease Brain: Tortuous and Torturous", DRUG NEWS PERSPECT., (2002), vol. 15, pages 549 - 557-
DESCRIPTION- SAATMAN, K.E.; BOZYCZKO-COYNE, D.; MARCY, V.; SIMAN, R.; MCINTOSH, T.K., "Prolonged calpain-mediated spectrin breakdown occurs regionally following experimental brain injury in the rat", J. NEUROPATHOL. EXP. NEUROL., (1996), vol. 55, pages 850 - 860-
DESCRIPTION- SAMBROOK ET AL.,, Molecular Cloning: A Laboratory Manual, 3rd ed.,, COLD SPRING HARBOR, (2001), vol. 1-3-
DESCRIPTION- SEIJO ET AL., J. CLIN. MICROBIOL., (2000), vol. 38, pages 3892 - 3895-
DESCRIPTION- SHIMOHAMA S; TANINO H; FUJIMOTO S., "Changes in caspase expression in Alzheimer's disease: comparison with development and aging", BIOCHEM BIOPHYS RES COMMUN., (1999), vol. 256, pages 381 - 384-
DESCRIPTION- SILVA, JM ET AL., CANCER RESEARCH, (1999), vol. 59, page 3251-
DESCRIPTION- SIMAN R; MCINTOSH TK; SOLTESZ KM; CHEN Z; NEUMAR RW; ROBERTS VL., "Proteins released from degenerating neurons are surrogate markers for acute brain damage", NEUROBIOL DIS., (2004), vol. 16, no. 2, pages 311 - 20-
DESCRIPTION- TAN E.M. ET AL., "Deoxyribonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus", J. CLIN. INVEST., (1966), vol. 45, pages 1732 - 1740-
DESCRIPTION- TERRYBERRY JW; SHOENFELD Y; PETER JB., "Clinical utility of autoantibodies in Guillain-Barre syndrome and its variants", CLIN REV ALLERGY IMMUNOL, (1998), vol. 16, pages 265 - 273-
DESCRIPTION- VAN DEN HEUVEL C; THORNTON E; VINK R., "Traumatic brain injury and Alzheimer's disease: a review", PROG BRAIN RES., (2007), vol. 161, pages 303 - 16-
DESCRIPTION- WANG, K.K.W., "Calpain and caspase: can you tell the difference", TRENDS NEUROSCI., (2000), vol. 23, pages 20 - 26, XP002605179-
DESCRIPTION- WARREN, M.W.; KOBEISSY, F.H.; HAYES, R.L.; GOLD, M.S.; WANG, K.K.W., "Concurrent calpain and caspase-3 mediated proteolysis of all-spectrin and tau in rat brain after methamphetamine exposure: A similar profile to traumatic brain injury", LIFE SCIENCES, (2005), vol. 78, pages 301 - 309-
DESCRIPTION- WARREN, MW. ZHENG; W.R., KOBEISSY; F., LIU; M.C.,, HAYES; R.L., GOLD; MARK, M.C. LIU; WANG, K.K.W., "Calpain and caspase mediated proteolysis of all-spectrin and tau in rat cerebrocortical neuron cultures after ecstasy (MDMA) or methamphetamine exposure", INT. J. NEUROPSYPHARM., (2006), vol. 9, pages 1 - 11-
DESCRIPTION- WATTS, RA ET AL., IMMUNOLOGY, (1990), vol. 69, no. 3, pages 348 - 354-
DESCRIPTION- WOUTERLOOD, Neuroscience Protocols modules, ELSEVIER, (1995), vol. 10-
DESCRIPTION- YANG L. S.; KSIEZAK-REDING, H., "Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments", J. BIOCHEM., (1995), vol. 233, pages 9 - 17-
DESCRIPTION- YE, J ET AL., PNAS USA, (2008), vol. 105, pages 82 - 87-
DESCRIPTION- YOSHIYAMA Y; URYU K; HIGUCHI M; LONGHI L; HOOVER R; FUJIMOTO S; MCINTOSH T; LEE VM; TROJANOWSKI JQ., "Enhanced neurofibrillary tangle formation, cerebral atrophy, and cognitive deficits induced by repetitive mild brain injury in a transgenic tauopathy mouse model", J NEUROTRAUMA, (2005), vol. 22, pages 134 - 1141-
DESCRIPTION- ZHANG JY; PENG C; SHI H; WANG S; WANG Q; WANG JZ., "Inhibition of autophagy causes tau proteolysis by activating calpain in rat brain", J ALZHEIMERS DIS., (2009), vol. 16, pages 39 - 47-
DESCRIPTION- ZHANG Z; LARNER S; LIU MC; ZHENG W; HAYES RL; WANG KKW., "Multiple all-spectrin Breakdown Products Distinguish Calpain and Caspase Dominated Necrotic and Apoptotic Cell Death Pathways", APOPTOSIS, (2009), vol. 14, doi:doi:10.1007/s10495-009-0405-z, pages 1289 - 1298, XP019745954
DESCRIPTION- GORYUNOVA AV; BAZARNAYA NA; SOROKINA EG ET AL., "Glutamate receptor autoantibody concentrations in children with chronic post-traumatic headache", NEUROSCI BEHAV PHYSIOL, (2007), vol. 37, doi:doi:10.1007/s11055-007-0079-3, pages 761 - 764, XP019555380
DESCRIPTION- JOHNSON, G.V.; JOPE, R.S.; BINDER, L.I., "Proteolysis of tau by calpain", BIOCHEM. BIOPHYS. RES. COMMUN., (1989), vol. 163, doi:doi:10.1016/0006-291X(89)91150-9, pages 1505 - 1511, XP024836785
DESCRIPTION- LITERSKY, J.M.; SCOTT, C.W.; JOHNSON, G.V., "Phosphorylation, calpain proteolysis and tubulin binding of recombinant human tau isoforms", BRAIN RES., (1993), vol. 604, doi:doi:10.1016/0006-8993(93)90349-R, pages 32 - 40, XP024282183
DESCRIPTION- DIXON, C.E.; CLIFTON, G.L.; LIGHTHALL J.W.; YAGHMAI, A.A.; HAYES, R.L., "A controlled cortical impact model of traumatic brain injury in the rat", J. NEUROSCI., (1991), vol. 39, doi:doi:10.1016/0165-0270(91)90104-8, pages 253 - 262, XP024342044
DESCRIPTION- NG, H.K.; MAHALIYANA, R.D.; POON, W.S., "The pathological spectrum of diffuse axonal injury in blunt head trauma: assessment with axon and myelin strains", CLIN. NEUROL. NEUROSURG., (1994), vol. 96, doi:doi:10.1016/0303-8467(94)90025-6, pages 24 - 31, XP024364985
DESCRIPTION- URYU K; CHEN XH; MARTINEZ D; BROWNE KD; JOHNSON VE; GRAHAM DI; LEE VM; TROJANOWSKI JQ; SMITH DH., "Multiple proteins implicated in neurodegenerative diseases accumulate in axons after brain trauma in humans", EXP NEUROL., (2007), vol. 208, doi:doi:10.1016/j.expneurol.2007.06.018, pages 185 - 92, XP022348691
DESCRIPTION- DELOBEL P; LEROY 0; HAMDANE M; SAMBO AV; DELACOURTE A; BUÉE L., "Proteasome inhibition and Tau proteolysis: an unexpected regulation", FEBS LETT., (2005), vol. 579, doi:doi:10.1016/j.febslet.2004.11.018, pages 1 - 5, XP004693365
DESCRIPTION- SINJOANU RC; KLEINSCHMIDT S; BITNER RS; BRIONI JD; MOELLER A; FERREIRA A., "The novel calpain inhibitor A-705253 potently inhibits oligomeric beta-amyloid-induced dynamin 1 and tau cleavage in hippocampal neurons", NEUROCHEM INT., (2008), vol. 53, no. 3-4, doi:doi:10.1016/j.neuint.2008.06.003, pages 79 - 88, XP023521087
DESCRIPTION- GUILLOZET-BONGAARTS AL; GARCIA-SIERRA F; REYNOLDS MR; HOROWITZ PM; FU Y; WANG T; CAHILL ME; BIGIO EH; BERRY RW; BINDER LI, "Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease", NEUROBIOL AGING., (2005), vol. 26, doi:doi:10.1016/j.neurobiolaging.2004.09.019, pages 1015 - 1022, XP004772153
DESCRIPTION- ZEMLAN, F.P.; JAUCH, E.C.; MULCHAHEY, J.J.; GABBITA, S.P.; ROSENBERG,W.S.; SPECIALE SG; ZUCCARELLO M., "C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome", BRAIN RES., (2002), vol. 23, doi:doi:10.1016/S0006-8993(02)02920-7, pages 131 - 139, XP002541417
DESCRIPTION- YEN, S.; EASSON, C.; NACHARAJU, P.; HUTTON, M.; YEN, S.H., "FTDP-17 tau mutations decrease the susceptibility of tau to calpain I digestion", FEBS LETT., (1999), vol. 461, doi:doi:10.1016/S0014-5793(99)01427-1, pages 91 - 95, XP004260527
DESCRIPTION- DAMBINOVA SA; IZYKENOVA GA; BUROV SV; GRIGORENKO EV; GROMOV SA, "The presence of autoantibodies to N-terminus domain of GluR1 subunit of AMPA receptor in the blood serum of patients with epilepsy", J NEUROL SCI, (1997), vol. 152, doi:doi:10.1016/S0022-510X(97)00150-0, pages 93 - 97, XP001096082
DESCRIPTION- TERRYBERRY JW; THOR G; PETER JB., "Autoantibodies in neurodegenerative diseases: antigen-specific frequencies and intrathecal analysis", NEUROBIOL AGING, (1998), vol. 19, doi:doi:10.1016/S0197-4580(98)00049-9, pages 205 - 216, XP002634049
DESCRIPTION- ZEMLAN, F.P.; MULCHAHEY, J.J.; GUDELSKY, G.A., "Quantification and localization of kainic acid-induced neurotoxicity employing a new biomarker of cell death: cleaved microtubule-associated protein-tau (C-tau", NEUROSCIENCE, (2003), vol. 121, doi:doi:10.1016/S0306-4522(03)00459-7, pages 399 - 409, XP055174382
DESCRIPTION- GAMBLIN TC; CHEN F; ZAMBRANO A; ABRAHA A; LAGALWAR S; GUILLOZET AL; LU M; FU Y; GARCIA-SIERRA F; LAPOINTE N, "Caspase cleavage of tau, linking amyloid and neurofibrillary tangles in Alzheimer's disease", PROC NATL ACAD SCI USA, vol. 100, doi:doi:10.1073/pnas.1630428100, pages 10032 - 10037, XP055053496
DESCRIPTION- SAATMAN, K.E.; MURAI, H.; BARTUS, R.T.; SMITH, D.H.; HAYWARD, N.J.; PERRI, B.R.; MCINTOSH T.K., "Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat", PROC. NATL ACAD. SCI. USA, (1996), vol. 93, doi:doi:10.1073/pnas.93.8.3428, pages 3428 - 3433, XP001206056
DESCRIPTION- BINDER, L.I.; FRANKFURTER, A.; REBHUN, L.I., "The distribution of tau in the mammalian central nervous system", J. CELL BIOL., (1985), vol. 101, doi:doi:10.1083/jcb.101.4.1371, pages 1371 - 1378, XP055161258
DESCRIPTION- GABBITA SP; SCHEFF SW; MENARD RM; ROBERTS K; FUGACCIA I; ZEMLAN FP., "Cleaved-tau: a biomarker of neuronal damage after traumatic brain injury", J NEUROTRAUMA, (2005), vol. 22, doi:doi:10.1089/neu.2005.22.83, pages 83 - 94, XP008087368
DESCRIPTION- NATH, R.; MCGINNIS, K.J.; NADIMPALLI, R.; STAFFORD, D.; WANG, K.K.W., "Effects of ICE-like proteases and calpain inhibitors on neuronal apoptosis", NEUROREPORT, (1996), vol. 8, doi:doi:10.1097/00001756-199612200-00050, pages 249 - 255, XP001030552
DESCRIPTION- PIKE, B.R.; ZHAO, X.; NEWCOMB, J.K.; POSMANTUR, R.M.; WANG, K.K.W.; HAYES, R.L., "Regional calpain and caspase-3 proteolysis of alpha-spectrin after traumatic brain injury", NEUROREPORT, (1998), vol. 9, doi:doi:10.1097/00001756-199808030-00002, pages 2437 - 2442, XP008067600
DESCRIPTION- SAATMAN, K.E; ZHANG, C.; BARTUS, R.T.; MCINTOSH, T.K., "Behavioral efficacy of posttraumatic calpain inhibition is not accompanied by reduced spectrin proteolysis, cortical lesion, or apoptosis", J. CEREB. BLOOD FLOW METAB., (2000), vol. 20, doi:doi:10.1097/00004647-200001000-00010, pages 66 - 73, XP009046091
DESCRIPTION- PIKE, B.R.; FLINT, J.; DAVE, J.R.; LU, X.C.; WANG, K.K.; TORTELLA, F.C.; HAYES, R.L., "Accumulation of calpain and caspase-3 proteolytic fragments of brain- derived alphall-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats", J CEREB BLOOD FLOW METAB., (2004), vol. 24, doi:doi:10.1097/01.WCB.0000098520.11962.37, pages 98 - 106, XP009071896
DESCRIPTION- ARNAUD LT; MYEKU N; FIGUEIREDO-PEREIRA ME., "Proteasome-caspase- cathepsin sequence leading to tau pathology induced by prostaglandin J2 in neuronal cells", J NEUROCHEM., (2009), vol. 110, no. 1, doi:doi:10.1111/j.1471-4159.2009.06142.x, pages 328 - 42, XP055119896
DESCRIPTION- RISSMAN RA; POON WW; BLURTON-JONES M; ODDO S; TORP R; VITEK MP; LAFERLA FM; ROHN TT; COTMAN CW., "Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology", J CLIN INVEST., (2004), vol. 114, no. 1, doi:doi:10.1172/JCI200420640, pages 121 - 30, XP002734348
DESCRIPTION- PARK SY; FERREIRA A., "The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration", J NEUROSCI., (2005), vol. 25, doi:doi:10.1523/JNEUROSCI.1125-05.2005, pages 5365 - 5375, XP008150389
EXAMINATION- CHEKHONIN V P ET AL, "Enzyme immunoassay of antibodies to neurospecific proteins in examination of blood-brain barrier function", IMMUNOLOGIA (MOSCOW), NEDICINA, MOSCOW, RU, (19960101), ISSN 0206-4952, pages 67 - 69, XP009181422-
INTERNATIONAL-SEARCH-REPORT- ROHN, T. T. ET AL., "Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain.", NEUROBIOL. DIS., (2002), vol. 11, pages 341 - 354, XP008157465
INTERNATIONAL-SEARCH-REPORT- COTMAN, C. W. ET AL., "The role of caspase cleavage of Tau in Alzheimer disease neuropathology.", J. NEUROPATHOL. EXP. NEUROL., (2005), vol. 64, no. 2, pages 104 - 112, XP008157467
INTERNATIONAL-SEARCH-REPORT- MOUSER, P. E. ET AL., "Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer's disease brain.", AM. J. PATHOL., (2006), vol. 168, no. 3, pages 936 - 946, XP008157492
OPPOSITION- CHEKHONIN et al., "Enzyme immunoassay of antibodies to neurospecific proteins in examination of blood-brain barrier function", Immunologiya, (19960000), pages 67 - 69, XP009184122-
OPPOSITION- MOROZOV et al., Vopr. Med. Khim., (19960000), vol. 42, no. 2, pages 147 - 52-
OPPOSITION- "Traumatic brain injury", Wikipedia, URL: https://en.wikipedia.orq/wiki/Traumatic_brain_injury-
OPPOSITION- SOROKINA et al., "Autoantibodies to Glutamate Receptors and Products of Nitric Oxide Metabolism in Serum in Children in the Acute Phase of Craniocerebral Trauma", Neuroscience and Behavioural Physiology, (20090000), vol. 39, no. 4, pages 329 - 334, XP055621114
OPPOSITION- SKODA et al., "Antibody formation against B-tubulin class III in response to brain trauma", Brain Research Bulletin, (20060000), vol. 68, pages 213 - 216, XP005222650
OPPOSITION- NYLEN et al., "Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome", J Neurol Sci, (20060000), vol. 240, pages 85 - 91, XP005215587
OPPOSITION- PELINKA et al., "Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma", J Trauma, (20040000), vol. 57, no. 5, pages 1006 - 1012, XP009511820
OPPOSITION- VOS et al., "Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury", Neurology, (20040000), vol. 62, pages 1303 - 1310, XP055030077
SEARCH- CHEKHONIN V P ET AL, "Enzyme immunoassay of antibodies to neurospecific proteins in examination of blood-brain barrier function", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (1996), Database accession no. PREV199699185328, XP002691422 [X] 1-3,11,12 * abstract *-
SEARCH[ ] - CHEKHONIN V P ET AL, "Enzyme immunoassay of antibodies to neurospecific proteins in examination of blood-brain barrier function", IMMUNOLOGIYA, (1996), vol. 0, no. 2, ISSN 0206-4952, pages 67 - 69-
SEARCH- MOROZOV S G ET AL, "[Autoantibodies against nerve tissue proteins long after cranio-cerebral injury].", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (199604), Database accession no. NLM9148602, XP002691424 [A] 1 * abstract *-
SEARCH[ ] - MOROZOV S G ET AL, "[Autoantibodies against nerve tissue proteins long after cranio-cerebral injury].", VOPROSY MEDITSINSKOI KHIMII 1996 APR-JUN, (199604), vol. 42, no. 2, ISSN 0042-8809, pages 147 - 152-
SEARCH- SOROKINA E G ET AL, "[Autoantibodies to glutamate receptors and metabolic products of nitric oxide in blood serum of children in the acute period of brain trauma].", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (2008), Database accession no. NLM18427542, XP002691423 [A] 1 * abstract *-
SEARCH[ ] - SOROKINA E G ET AL, "[Autoantibodies to glutamate receptors and metabolic products of nitric oxide in blood serum of children in the acute period of brain trauma].", ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S.S. KORSAKOVA / MINISTERSTVO ZDRAVOOKHRANENIIA I MEDITSINSKOI PROMYSHLENNOSTI ROSSIISKOI FEDERATSII, VSEROSSIISKOE OBSHCHESTVO NEVROLOGOV [I] VSEROSSIISKOE OBSHCHESTVO PSIKHIATROV 2008, (2008), vol. 108, no. 3, ISSN 1997-7298, pages 67 - 72-
SEARCH- JOHN B. REDELL ET AL, "Traumatic brain injury alters expression of hippocampal microRNAs: Potential regulators of multiple pathophysiological processes", JOURNAL OF NEUROSCIENCE RESEARCH, (20090501), vol. 87, no. 6, doi:10.1002/jnr.21945, ISSN 0360-4012, pages 1435 - 1448, XP055051729 [A] 1 * abstract *
SEARCH- S. RUDEHILL ET AL, "Autoreactive antibodies against neurons and basal lamina found in serum following experimental brain contusion in rats", ACTA NEUROCHIRURGICA, (20060201), vol. 148, no. 2, doi:10.1007/s00701-005-0673-5, ISSN 0001-6268, pages 199 - 205, XP055051450 [A] 1-3 * abstract *
SEARCH- HOZUMI I ET AL, "GFAP mRNA levels following stab wounds in rat brain", BRAIN RESEARCH, ELSEVIER, AMSTERDAM, NL, vol. 534, no. 1-2, doi:10.1016/0006-8993(90)90142-X, ISSN 0006-8993, (19901126), pages 291 - 294, (19901126), XP024264399 [A] 1,2 * abstract *
SEARCH- PRINCE G L ET AL, "Alterations of glial fibrillary acidic protein mRNA level in the aging brain and in senile dementia of the Alzheimer type", NEUROSCIENCE LETTERS, LIMERICK, IE, vol. 151, no. 1, doi:10.1016/0304-3940(93)90048-P, ISSN 0304-3940, (19930305), pages 71 - 73, (19930305), XP024360875 [A] 1,2 * abstract *
SEARCH- SKODA D ET AL, "Antibody formation against beta-tubulin class III in response to brain trauma", BRAIN RESEARCH BULLETIN, ELSEVIER SCIENCE LTD, OXFORD, GB, vol. 68, no. 4, doi:10.1016/J.BRAINRESBULL.2005.05.032, ISSN 0361-9230, (20060115), pages 213 - 216, (20060115), XP024900581 [A] 1-3 * abstract *
SEARCH- YOUNG B. LEE ET AL, "Rapid increase in immunoreactivity to GFAP in astrocytes in vitro induced by acidic pH is mediated by calcium influx and calpain I", BRAIN RESEARCH, (20000501), vol. 864, no. 2, doi:10.1016/S0006-8993(00)02180-6, ISSN 0006-8993, pages 220 - 229, XP055051392 [I] 1-3 * abstract *
SEARCH- F. TANRIVERDI ET AL, "Antipituitary antibodies after traumatic brain injury: is head trauma-induced pituitary dysfunction associated with autoimmunity?", EUROPEAN JOURNAL OF ENDOCRINOLOGY, (20080701), vol. 159, no. 1, doi:10.1530/EJE-08-0050, ISSN 0804-4643, pages 7 - 13, XP055051280 [A] 1-3 * abstract *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents